Study 3 of 22 for search of: "Strabismus"
Previous Study Return to Search Results Next Study

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Povidone-Iodine Antisepsis for Strabismus Surgery (PASS)
This study is not yet open for participant recruitment.
Verified by Erasmus Medical Center, April 2007
Sponsors and Collaborators: Erasmus Medical Center
Ludwig-Maximilians - University of Munich
University of Heidelberg
University Hospital, Essen
University of Giessen
University Hospital Freiburg
Ernst Moritz Arndt University of Greifswald
Radboud University
Free University Medical Center
Leiden University Medical Center
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Information provided by: Erasmus Medical Center
ClinicalTrials.gov Identifier: NCT00461656
  Purpose

The purpose of this study is to compare the efficacy of 5 % vs. 1.25 % povidone-iodine (PI) as preoperative antiseptic prior to strabismus surgery in children as a prophylaxis of endophthalmitis. Given the low rate of endophthalmitis the conjunctival bacterial flora rate is used as surrogate marker to determine the effectiveness of topical PI in reducing or eliminating bacteria from the ocular surface at the time of the surgery. Secondary objective is a reduction of the incidence of postoperative endophthalmitis after strabismus surgery in young children.


Condition Intervention Phase
Strabismus
Surgery
Endophthalmitis
Drug: Preoperative conjunctival irrigation with 5% or 1.25% PI
Phase IV

Drug Information available for: Iodine Cadexomer iodine Povidone-iodine Povidone
U.S. FDA Resources
Study Type: Interventional
Study Design: Prevention, Randomized, Double-Blind, Dose Comparison, Parallel Assignment, Efficacy Study
Official Title: Prospective, Randomized, Double-Blind Comparison of 5 % Against 1.25 % Povidone-Iodine Solution as Preoperative Antisepsis for Strabismus Surgery in Young Children

Further study details as provided by Erasmus Medical Center:

Primary Outcome Measures:
  • The difference in the mean numbers of bacterial colony forming units from pre-irrigation to post-irrigation with PI.

Secondary Outcome Measures:
  • Iodine excretion after surgery, assessed as urine iodine concentration per creatinine clearance.
  • Postoperative erosion of the cornea and corneal oedema.

Estimated Enrollment: 200
Study Start Date: September 2007
Estimated Study Completion Date: September 2009
Detailed Description:

Background: Endophthalmitis after strabismus surgery in young children leads to blindness and loss of the affected eye. It is caused by conjunctival bacteria. PI solutions between 1% and 5% reduce the number of bacteria on the conjunctiva. The concentration used varies widely among clinics, from 1% to 5%. In vitro studies have shown that PI is paradoxically more effective at lower concentration, but in cataract surgery in elderly, 1% PI has been shown to be less effective than 5% PI. Dilution by tear fluid or binding of PI to proteins in tear fluid may lower its effectiveness. Since endophthalmitis after strabismus surgery especially affects young children and the bacterial flora of the conjunctiva in children is different from that in adults, the cataract PI study should be repeated in young children operated for strabismus.

Objective: To compare the efficacy of 5 % vs. 1.25 % povidone-iodine (PI) as preoperative antiseptic prior to strabismus surgery in children as a prophylaxis of endophthalmitis. Given the low rate of endophthalmitis the conjunctival bacterial flora rate is used as surrogate marker to determine the effectiveness of topical PI in reducing or eliminating bacteria from the ocular surface at the time of the surgery.

Design: The study is a multi-centre, prospective, randomized-controlled, parallel-groups, assessor-blind (microbiological assessments), investigator-initiated trial.

Study population: All children under 6 years of age attending the 15 participating clinics for routine strabismus surgery will be eligible for the study at the point that a strabismus operation is planned. The clinics (5 Dutch, 10 German) will each recruit approximately 20 patients. The minimum sample size is 2 x 100 patients.

Intervention: Diluted PI, 1.25% or 5%, will be prepared in a sterile fashion, and distributed in single-use dispensers. These will be coded for randomization. Before initiation of surgery, children randomized to the 5% PI group will have their conjunctival fornices irrigated with 5 ml PI 5%. Children randomized to the 1.25% PI group will have their conjunctival fornices irrigated with 5 ml PI 1.25%. Conjunctiva cultures for aerobic and anaerobic bacteria will be obtained (1) after general anesthesia has been established, (2) 5-10 min after PI irrigation, (3) after reattachment of the eye muscles and (4) after closing the conjunctiva with sutures.

Primary outcome: The difference in the mean numbers of bacterial colony forming units (CFUs) from pre-irrigation (l) to post-irrigation with PI (2-4).

Secondary outcome: Iodine excretion after surgery, assessed as urine iodine concentration per creatinine clearance.

Postoperative erosion of the cornea and corneal oedema. Both of these have been described as side-effects of PI use.

Nature and extent of the burden and risks associated with participation:

Risks are limited to the act of taking the four bacterial cultures, as both 1.25% PI and 5% PI are approved preoperative antiseptic applications of PI and both are used, rather indiscriminately, by the university departments of ophthalmology participating in the study.

  Eligibility

Ages Eligible for Study:   up to 6 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Children attending for routine strabismus surgery are eligible for the study. Criteria for inclusion:

  1. Children < 6 years of age
  2. undergoing surgery for strabismus for the first time, including any recession and/or resection surgery of the medial and/or lateral rectus muscles.
  3. willing to take part in all aspects of the study with written informed consent on the study participation of the child provided by the parents.

Exclusion Criteria:

  1. Any history or current condition of hypersensitivity to iodine
  2. Children on topical antibiotic within the last 30 days
  3. Children with signs of acute conjunctivitis, blepharitis, dacryocystitis or respiratory infection within the last 30 days
  4. Children with asthma or similar chronic, obstructive pulmonary disorder
  5. Insufficiently treated amblyopia, i.e. a difference between the visual acuities of both eyes larger than 1 LogMARline.
  6. Neurological or psychiatric disorder, medication, other eye disorder, decreased visual acuity caused by brain damage or trauma.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00461656

Contacts
Contact: Huibert J Simonsz, MD PhD +31651187878 simonsz@compuserve.com
Contact: Herminia Miño de Kaspar, PhD `+498951603890 hminokaspar@cs.com

Locations
Germany
Universitäts-Augenklinik
Essen, Germany, D-45147
Universitäts-Augenklinik
Freiburg, Germany, D-79106
Universitäts-Augenklinik
Erlangen, Germany, D-91054
Universitäts-Augenklinik
Heidelberg, Germany, D-69120
Universitäts-Augenklinik Universitätsklinikum
Dresden, Germany, D-01307
Universitäts-Augenklinik Ludwig-Maximilian University
Munich, Germany, D-80336
Universitäts-Augenklinik
Gießen, Germany, D-35385
Universitäts-Augenklinik
Lübeck, Germany, D-23538
Universitäts-Augenklinik
Regensburg, Germany, D-93053
Universitäts-Augenklinik
Mainz, Germany, D-55101
Universitäts-Augenklinik
Greifswald, Germany, D-17487
Universitäts-Augenklinik
Magdeburg, Germany, D-39120
Netherlands
Dept. of Ophthalmology Erasmus Medical Center
Rotterdam, Netherlands, NL3000CA
Dept. of Ophthalmology St. Laurentius Ziekenhuis
Roermond, Netherlands, NL-6040AX
Dept. Ophthalmology
Leiden, Netherlands, NL-2300RC
Dept. Ophthalmology Free University Medical Center
Amsterdam, Netherlands, NL-1007MB
Dept. Ophthalmology Academical Medical Center
Amsterdam, Netherlands, NL-1105AZ
Dept Ophthalmology University Nijmegen Medical Center
Nijmegen, Netherlands, NL-6500HB
Sponsors and Collaborators
Erasmus Medical Center
Ludwig-Maximilians - University of Munich
University of Heidelberg
University Hospital, Essen
University of Giessen
University Hospital Freiburg
Ernst Moritz Arndt University of Greifswald
Radboud University
Free University Medical Center
Leiden University Medical Center
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Investigators
Principal Investigator: Huibert J Simonsz, MD PhD Erasmus Medical Center
Principal Investigator: Herminia Miño de Kaspar, PhD Universitäts-Augenklinik Ludwig-Maximilian University Munich Germany
  More Information

Publications:
Anderson RL, Vess RW, Carr JH, Bond WW, Panlilio AL, Favero MS. Investigations of intrinsic Pseudomonas cepacia contamination in commercially manufactured povidone-iodine. Infect Control Hosp Epidemiol. 1991 May;12(5):297-302.
Apt L, Isenberg S, Yoshimori R, Paez JH. Chemical preparation of the eye in ophthalmic surgery. III. Effect of povidone-iodine on the conjunctiva. Arch Ophthalmol. 1984 May;102(5):728-9.
Bannerman TL, Rhoden DL, McAllister SK, Miller JM, Wilson LA. The source of coagulase-negative staphylococci in the Endophthalmitis Vitrectomy Study. A comparison of eyelid and intraocular isolates using pulsed-field gel electrophoresis. Arch Ophthalmol. 1997 Mar;115(3):357-61.
Berkelman RL, Holland BW, Anderson RL. Increased bactericidal activity of dilute preparations of povidone-iodine solutions. J Clin Microbiol. 1982 Apr;15(4):635-9.
Binder CA, Mino de Kaspar H, Klauss V, Kampik A. [Preoperative infection prophylaxis with 1% polyvidon-iodine solution based on the example of conjunctival staphylococci] Ophthalmologe. 1999 Oct;96(10):663-7. German.
Caldwell DR, Kastl PR, Cook J, Simon J. Povidone-iodine: its efficacy as a preoperative conjunctival and periocular preparation. Ann Ophthalmol. 1984 Jun;16(6):577, 580.
Carothers TS, Coats DK, McCreery KM, Rossman SN, Wilson P, Wu TG, Paysse EA. Quantification of incidental needle and suture contamination during strabismus surgery. Binocul Vis Strabismus Q. 2003;18(2):75-9.
Ciulla TA, Starr MB, Masket S. Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update. Ophthalmology. 2002 Jan;109(1):13-24. Review.
Davis GH, Finlayson N, Kemp R. Dilution of povidone-iodine. Med J Aust. 1985 Sep 30;143(7):321. No abstract available.
Dereklis DL, Bufidis TA, Tsiakiri EP, Palassopoulos SI. Preoperative ocular disinfection by the use of povidone-iodine 5%. Acta Ophthalmol (Copenh). 1994 Oct;72(5):627-30.
Ferguson AW, Scott JA, McGavigan J, Elton RA, McLean J, Schmidt U, Kelkar R, Dhillon B. Comparison of 5% povidone-iodine solution against 1% povidone-iodine solution in preoperative cataract surgery antisepsis: a prospective randomised double blind study. Br J Ophthalmol. 2003 Feb;87(2):163-7.
Grimes SR, Hollsten D, Nauschuetz WF, Whiddon RG, Trevino SB. Effect of povidone-iodine irrigation on the preoperative chemical preparation of the eye. Mil Med. 1992 Mar;157(3):111-3.
Katosova LK. [The features of Haemophilus influenza and Streptococcus pneumoniae carriage and the comparative characteristics of strains isolated from healthy children and from patients with acute and chronic respiratory infections] Zh Mikrobiol Epidemiol Immunobiol. 1994 Aug-Sep;Suppl 1:55-60. Russian.
Khashu M, Chessex P, Chanoine JP. Iodine overload and severe hypothyroidism in a premature neonate. J Pediatr Surg. 2005 Feb;40(2):E1-4.
Lacey RW, Catto A. Action of povidone-iodine against methicillin-sensitive and -resistant cultures of Staphylococcus aureus. Postgrad Med J. 1993;69 Suppl 3:S78-83.
Mino de Kaspar H, Chang RT, Singh K, Egbert PR, Blumenkranz MS, Ta CN. Prospective randomized comparison of 2 different methods of 5% povidone-iodine applications for anterior segment intraocular surgery. Arch Ophthalmol. 2005 Feb;123(2):161-5.
Olitsky SE, Vilardo M, Awner S, Reynolds JD. Needle sterility during strabismus surgery. J AAPOS. 1998 Jun;2(3):151-2.
Prince HN, Nonemaker WS, Norgard RC, Prince DL. Drug resistance studies with topical antiseptics. J Pharm Sci. 1978 Nov;67(11):1629-31.
Recchia FM, Baumal CR, Sivalingam A, Kleiner R, Duker JS, Vrabec TR. Endophthalmitis after pediatric strabismus surgery. Arch Ophthalmol. 2000 Jul;118(7):939-44.
Roberts SM, Severin GA, Lavach JD. Antibacterial activity of dilute povidone-iodine solutions used for ocular surface disinfection in dogs. Am J Vet Res. 1986 Jun;47(6):1207-10.
Singer TR, Isenberg SJ, Apt L. Conjunctival anaerobic and aerobic bacterial flora in paediatric versus adult subjects. Br J Ophthalmol. 1988 Jun;72(6):448-51.
Speaker MG, Milch FA, Shah MK, Eisner W, Kreiswirth BN. Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology. 1991 May;98(5):639-49; discussion 650.
Speaker MG, Menikoff JA. Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology. 1991 Dec;98(12):1769-75.
Zamora JL. Chemical and microbiologic characteristics and toxicity of povidone-iodine solutions. Am J Surg. 1986 Mar;151(3):400-6. Review.
Zamora JL, Price MF, Chuang P, Gentry LO. Inhibition of povidone-iodine's bactericidal activity by common organic substances: an experimental study. Surgery. 1985 Jul;98(1):25-9.

Study ID Numbers: ABR 14357
Study First Received: April 17, 2007
Last Updated: April 17, 2007
ClinicalTrials.gov Identifier: NCT00461656  
Health Authority: Netherlands: The Central Committee on Research Involving Human Subjects (CCMO);   Germany: Federal Institute for Drugs and Medical Devices

Keywords provided by Erasmus Medical Center:
Antiseptic
Povidone-Iodine

Study placed in the following topic categories:
Bacterial Infections
Eye Infections, Bacterial
Motor neuro-ophthalmic disorders
Eye Diseases
Strabismus
Eye Infections
Endophthalmitis
Povidone-Iodine
Ocular motility disorders
Mycoses
Ocular Motility Disorders
Uveitis
Povidone
Suppuration
Iodine

Additional relevant MeSH terms:
Anti-Infective Agents
Uveal Diseases
Growth Substances
Physiological Effects of Drugs
Nervous System Diseases
Hematologic Agents
Trace Elements
Infection
Eye Infections, Fungal
Pharmacologic Actions
Anti-Infective Agents, Local
Therapeutic Uses
Blood Substitutes
Micronutrients
Uveitis, Suppurative
Cranial Nerve Diseases
Plasma Substitutes

ClinicalTrials.gov processed this record on January 16, 2009